Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium Carbonate and Raltegravir Pharmacokinetics in HIV
NCT04258475Phase 4Unknown
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Dec 2020
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
A Phase 4 trial of raltegravir in human immunodeficiency virus infection (HIV), sponsored by Ottawa Hospital Research Institute. Status: unknown.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT04258475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04258475.